These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Valproate-caused encephalopathy]. Thygesen KS; Wolf P Ugeskr Laeger; 2005 Oct; 167(40):3793-4. PubMed ID: 16221398 [TBL] [Abstract][Full Text] [Related]
4. Is valproate encephalopathy under-recognised in older people? A case series. Beyenburg S; Back C; Diederich N; Lewis M; Reuber M Age Ageing; 2007 May; 36(3):344-6. PubMed ID: 17374600 [TBL] [Abstract][Full Text] [Related]
5. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome]. Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484 [TBL] [Abstract][Full Text] [Related]
6. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854 [TBL] [Abstract][Full Text] [Related]
7. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012. Cheng M; Tang X; Wen S; Yue J; Wang H Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children. Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750 [TBL] [Abstract][Full Text] [Related]
9. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy]. Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301 [TBL] [Abstract][Full Text] [Related]
10. Sodium valproate-related hyperammonaemic encephalopathy. Pegg EJ; Zaman F BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24722719 [TBL] [Abstract][Full Text] [Related]
11. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367 [TBL] [Abstract][Full Text] [Related]
13. A case of hyperammonaemic encephalopathy due to valproic acid. Prins MC; van Meijel JJ Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982 [TBL] [Abstract][Full Text] [Related]
15. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India. Mehndiratta MM; Mehndiratta P; Phul P; Garg S J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136 [TBL] [Abstract][Full Text] [Related]
16. [The decreased level of plasma carnitine in patients with epilepsy]. Belousova ED Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680 [TBL] [Abstract][Full Text] [Related]